Search results
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
CNBC· 17 hours agoNovo Nordisk and Eli Lilly have long dominated the rapidly growing weight loss drug market, but...
Eli Lilly Alzheimer’s drug gets FDA panel date after approval delay
The Hill via AOL· 17 hours agoAn outside panel of advisers to the Food and Drug Administration (FDA) will meet next month to...
Fox News host Jesse Watters calls out anti-Israel college protesters: ‘They want to rage but live...
New York Post· 9 hours agoJesse Watters. Born Philly. Quaker school. History major. Next a busboy, fired as a bellhop, worked...
Future pandemics will have the same human causes as ancient outbreaks − lessons from anthropology...
The Conversation via Yahoo News· 20 hours agoThis is the third epidemiological transition: the rise of new, virulent and drug-resistant...
Inflation’s hit to the FDA
Politico· 16 hours ago“We continue to engage drug companies and the public as we build on what we are learning in the first cycle of negotiations,” CMS Administrator Chiquita Brooks-LaSure said ...
How sham patents are hurting the pharma industry
Pharmaceutical Technology via Yahoo Finance· 1 day ago“[The Orange Book] is a very...litigation,” he adds. “If they lost, the generic faces potentially massive liability. A smaller generic company could even...
Pfizer Is Adding a Wall Street Analyst to Its C-Suite. What He Thinks the Company Needs to Do.
Barrons.com· 2 days agoSTOCK ALERT Andrew Baum, the prominent Wall Street drug company analyst, has never been much of a...
Hygrovest increases Net Asset Value per share by 23% to A$0.1355 in April
Proactive Investors· 2 hours ago...due to a 50% increase in the Enterprise Value to Net Revenue Multiple (EV/NRM) used by HGV when...
Innovent Receives NMPA Breakthrough Therapy Designation for IBI343（Anti-Claudin18.2 ADC）as...
ThePress.net· 1 day agoInnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the ...
VYNE Therapeutics receives FDA approval for trial of VYN202
Clinical Trials Arena via Yahoo Finance· 22 hours agoThe company expects to report top-line results from the SAD/MAD trial in the second half...optimal...
